Immune
system
monitoring
at scale
In a world full of pathogens, understanding immunity is essential.
Capture Bioscience’s platform delivers scalable, comprehensive insights into immune protection — enabling new opportunities in research, clinical development, public health monitoring, and personalized medicine.
Our novel highly multiplexed microbead-based assay measures protective antibodies across vaccines, infections, and exposures, providing a detailed picture of immune status.
The platform is built for scale: Performing over 100 times more tests per run than leading commercial assays. Its high-throughput design delivers deep, cost-effective insights into immune responses at unprecedented resolution.
Technology
Meet the Team
-
David McIlwain, PhD – Co-founder, CEO
Immunologist with 15+ years of experience in infectious diseases and immune profiling.
-
Alexandros Drainas, PhD – Co-founder, Operations lead
Expert in large-scale screening, data operations, and organizational leadership.
-
Xavier Rovira Clavé, PhD – Co-founder, Technology lead
Specialist in immune system analysis and high-throughput technology development.
-
Julien Sage, PhD – Co-founder, Scientific advisor
Stanford professor with deep expertise in cancer biology and biotech innovation.
-
Garry Nolan, PhD – Co-founder, Scientific advisor
Stanford professor and serial entrepreneur behind multiple pioneering immune analysis technologies.
-
Scott Dylla, PhD – Advisor
Former Founder & CSO at Stemcentrx; SVP of R&D, AbbVie